foxo4-dri senolytic peptide 2024 study

foxo4-dri senolytic peptide 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI UK | Senolytic Peptide

Name: foxo4-dri senolytic peptide 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI UK | Senolytic Peptide
Brand: eipa.cz
SKU: 19049610029
Price: 20.12 USD
Availability: InStock
Rating: 4.1863 (20 reviews)

FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 19049610029 · From eipa.cz

4.2

USD20.12 USD48.12

Pay in 4 interest-free payments of $5.03 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Please familiarize yourself with our Terms & Conditions prior to ordering

research-grade peptides are not evaluated for clinical efficacy or safety in human use [11]

A previous CSP analysis using FOXO4 FHD titration of 15 N-labeled p53 TAD showed that significant perturbations two standard deviations above average were mostly observed in residues within the p53 TAD2 region 38